Paul Aisen, MD
Founding Director, USC Alzheimer's Therapeutic Research InstituteProfessor of Neurology, Keck School of Medicine of USC
This paper revisits expert predictions for future advances in Alzheimer’s disease (AD) made in 2001 and projects future breakthroughs over the next 20 years.
Even modest delays in the progression of Alzheimer’s disease could dramatically alter the current trajectory and generate large health benefits.